Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis)
Featured Articles
(Roche) June 15, 2018 - Roche today announced data from the final analysis of the CLL11 study evaluating Gazyva®/Gazyvaro® (obinutuzumab)-based treatment in previously untreated chronic lymphocytic leukaemia (CLL) which will be presented during the Presidential Symposium at the 23rd European Hematology Association (EHA) Annual...
Read Article
(MD Anderson) June 16, 2018 - A study led by The University of Texas MD Anderson Cancer Center revealed that the investigational drug quizartinib prolonged overall survival for patients with a deadly form of acute myeloid leukemia (AML) linked to a genetic mutation called FMS-like internal tandem duplications (FLT3-ITD).
Read Article
Latest Articles
June 21, 2018
June 21, 2018
June 19, 2018
June 19, 2018
June 19, 2018
June 18, 2018
June 18, 2018
June 18, 2018
View More
News Commentary
Editor Image
05 Sep, 2017 | by Thomas Marsland, MD
WOW...that is a hunk of change...BUT it would appear that Novartis is at least...
View Comment
Editor Image
05 Oct, 2017 | by Thomas Marsland, MD
This is an interesting concept. Although this sounds good it may not in the...
View Comment
View More
OBR Green
View More
OBR Blog
There are no Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis) blog entries.